Literature DB >> 15345965

Thermal injury resulting from application of a granular mineral hemostatic agent.

James K Wright1, John Kalns, Edward A Wolf, Frederick Traweek, Stacy Schwarz, CleAnn K Loeffler, William Snyder, Loudon D Yantis, Jeffrey Eggers.   

Abstract

BACKGROUND: Uncontrolled hemorrhage accounts for the majority of deaths in combat. Effective topical hemostatic agents suitable for use on the battlefield may be valuable in controlling hemorrhage until definitive surgical intervention is possible. In an effort to identify a hemostatic agent suitable for battlefield use, we evaluated several potential hemostatic agents in a swine injury model and noted thermal injury to tissues with a granular mineral hemostatic agent (QuikClot).
METHODS: Anesthetized swine were maintained with a mean arterial pressure in excess of 60 mm Hg. Cutaneous, muscular, hepatic, splenic, venous, and arterial wounds were created in a standardized fashion. Topical hemostatic agents were immediately applied to the wounds and the amount of bleeding and time to hemostasis were noted.
RESULTS: The results reported here are part of a larger study in which a variety of hemostatic agents were evaluated. Only the findings related to the granular mineral hemostatic agent are discussed here. Application of the agent resulted in elevated tissue surface temperatures in excess of 95 degrees C and internal tissue temperatures exceeding 50 degrees C, 3 mm deep to the bleeding surface. Necrosis of fat and muscle were noted as well as full and partial thickness cutaneous burns.
CONCLUSIONS: Topical administration of a granular mineral hemostatic agent to a variety of wounds in an experimental swine model resulted in thermal tissue injury and necrosis. Suggestions for reducing the extent of injury with this product are offered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345965     DOI: 10.1097/01.ta.0000105916.30158.06

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  14 in total

Review 1.  Topical and effective hemostatic medicines in the battlefield.

Authors:  Yin-Juan Zhang; Bo Gao; Xi-Wen Liu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Host-guest composites for induced hemostasis and therapeutic healing in traumatic injuries.

Authors:  Todd A Ostomel; Peter K Stoimenov; Patricia A Holden; Hasan B Alam; Galen D Stucky
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

3.  Athermal nerve sparing robot-assisted radical prostatectomy: initial experience with microporous polysaccharide hemospheres as a topical hemostatic agent.

Authors:  Rafael Nunez-Nateras; Kimberly J Hurd; Erin N Ferrigni; Erik P Castle; Paul E Andrews; Mitchell R Humphreys
Journal:  World J Urol       Date:  2011-12-25       Impact factor: 4.226

4.  In situ gelling and dissolvable hydrogels for use as on-demand wound dressings for burns.

Authors:  Katherine A Cook; Nada Naguib; Jack Kirsch; Katherine Hohl; Aaron H Colby; Robert Sheridan; Edward K Rodriguez; Ara Nazarian; Mark W Grinstaff
Journal:  Biomater Sci       Date:  2021-10-12       Impact factor: 7.590

5.  Zeolite-based hemostat QuikClot releases calcium into blood and promotes blood coagulation in vitro.

Authors:  Jing Li; Wei Cao; Xiao-xing Lv; Li Jiang; Yue-jun Li; Wang-zhou Li; Shao-zong Chen; Xue-yong Li
Journal:  Acta Pharmacol Sin       Date:  2013-01-21       Impact factor: 6.150

Review 6.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

7.  Renal injury and the application of polysaccharide hemospheres: a laparoscopic experimental model.

Authors:  Mitchell R Humphreys; James E Lingeman; Colin Terry; Erik P Castle; Paul E Andrews; Matthew T Gettman; Mark H Ereth
Journal:  J Endourol       Date:  2008-06       Impact factor: 2.942

Review 8.  Hemostatic strategies for traumatic and surgical bleeding.

Authors:  Adam M Behrens; Michael J Sikorski; Peter Kofinas
Journal:  J Biomed Mater Res A       Date:  2013-12-12       Impact factor: 4.396

9.  Enhanced hemostatic performance of tranexamic acid-loaded chitosan/alginate composite microparticles.

Authors:  Donghong Li; Pengxi Li; Jiatao Zang; Jiancang Liu
Journal:  J Biomed Biotechnol       Date:  2012-11-05

10.  The iTClamp controls junctional bleeding in a lethal swine exsanguination model.

Authors:  Dennis Filips; Sarvesh Logsetty; Jonathan Tan; Ian Atkinson; Kelly Mottet
Journal:  Prehosp Emerg Care       Date:  2013-08-22       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.